Lymphoma Cancer | Tumor

CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.

FDA Approves Brukinsa for Marginal Zone Lymphoma Treatment

September 15th 2021, 1:18pm

Article

Patients with relapsed/refractory, pretreated marginal zone lymphoma are now eligible for treatment with Brukinsa.

Can a Blood Test Predict Lymphoma Relapse?

September 3rd 2021, 4:00pm

Video

Circulating tumor DNA found in blood plasma may help predict if the likelihood of relapse for patients with large B-cell lymphoma, according to recent research.

Patients With Blood Cancers and COVID-19 May Benefit From Convalescent Plasma Therapy

September 2nd 2021, 9:00pm

Article

The use of convalescent plasma therapy in patients with blood cancers and COVID-19 was associated with an improvement in survival from the infection.

Brukinsa Receives FDA Approval for Treatment of Waldenstrom’s Macroglobulinemia

September 1st 2021, 10:29pm

Article

The FDA approval of Brukinsa, according to an expert from the Dana-Farber Cancer Institute, provides an important new option for targeted therapy in Waldenstrom’s macroglobulinemia.

Caring for a Patient With Lymphoma Also Includes the Caregiver

September 1st 2021, 1:00pm

Article

A recent webinar from the Lymphoma Research Foundation gave important advice for caregivers, including the importance of taking care of oneself.

Blood Cancer Survivors Should Not Rely on COVID-19 Antibody Tests to Determine Immunity

August 24th 2021, 1:00pm

Article

Patients with blood cancers may be less likely to derive immunity from the COVID-19 vaccine, though antibody tests should not be the end-all-be-all in guiding their behavior.

Investigational Cancer Treatment Being Evaluated in B-Cell Malignancies

August 23rd 2021, 9:00pm

Article

Researchers are evaluating the safety and efficacy of zandelisib, an investigational cancer therapy, for the treatment of patients with marginal zone lymphoma and follicular lymphoma who have received at least two prior therapies.

Drug Combo Provides Clinical Benefit With Fewer Side Effects in B-Cell Lymphoma

August 20th 2021, 9:00pm

Video

Combining PI3 kinase inhibitors with BTK inhibitors can mitigate side effects traditionally seen with PI3 kinase inhibitors, according to recent research.

The Olympic Silver Medalist Who Survived Cancer: Kevin McDowell Shares His Story

August 19th 2021, 3:00pm

Podcast

In this episode of the “CURE® Talks Cancer” podcast, Olympic triathlete Kevin McDowell discusses his cancer journey and shares some insight on his experiences at the Tokyo 2020 Olympics.

AYA Patients Are Represented in Clinical Trials, But Survival Outcomes Still Lag

August 12th 2021, 9:00pm

Article

Adolescent and young adult patients are more represented than previously expected in clinical trials. However, their outcomes still lag behind the younger and older populations.